Deceuninck – Quick-step Wins Second Consecutive Amgen Tour Of California Stage with Cavagna’s Powerful Solo Ride To The Finish
May 14, 2019
EF Education First Defends van Garderen’s Overall Race Lead. Tomorrow Cyclists Will Contest 129 Miles from Stockton to Morgan Hill
MORGAN HILL, Calif. (May 14, 2019) – For the second day in a row, a Deceuninck – Quick-Step cyclist claimed his first WorldTour stage win at the Amgen Tour of California, with 23-year-old French rider Rémi Cavagna spending hours on a solo ride several minutes ahead of the peloton.
About an hour into the race day, a breakaway including the USA Cycling National Team’s reigning U.S. U23 National Champion Alex Hoehn (Lenexa, Kansas) and Cavagna (FRA) built their lead to over 10 minutes and ended up spending 100 miles out front of the peloton.
Stage 3 presented by TAG Heuer featured a 129.2-mile ride from Stockton to Morgan Hill, including the first HC (above category) climb of the race at Mt. Hamilton. A pack of EF Education First Pro Cycling riders led the peloton, protecting their race leader Tejay van Garderen (Tacoma, Wash.) and pulling the gap down by a couple of minutes as the stage progressed. Van Garderen came over the Morgan Hill finish line with his six-second overall race lead intact to retain the Amgen Race Leader Jersey, in the same city where he picked up the 2018 yellow jersey for two days following the Time Trial stage in last year’s race.
Cavagna attacked Hoehn at the base of Mt. Hamilton, lengthening his lead on the way up to crest the summit and continue the rest of the stage solo, securing the Breakaway from Cancer® Most Courageous Rider Jersey for his efforts. Coming over that summit second as well as on the final King of the Mountain (KOM) climb of the day on Quimby Road, Hoehn moves into the lead in the KOM competition and will wear the polka dot jersey tomorrow.
Simon Geschke (GER), a Tour de France stage winner riding for the CCC Team, broke away from the pack to chase the leaders at around 15 miles left to ride and was soon joined by Team Dimension Data’s Ben King (Charlottesville, VA). The duo caught Hoehn about two miles from the finish line, with King sprinting to the second-place stage finish, and Geschke taking third.
The peloton of 19 teams (132 riders) representing 33 countries includes three World Champions, Olympians, Tour de France stage winners and six current National Road Race Champions from around the world. Throughout the week, cyclists will contest 773 miles of California’s most scenic highways, mountain roads and coastlines, visiting 13 cities throughout the state for stage starts and finishes, concluding in Pasadena on May 18.
Tomorrow’s Stage 4 presented by Lexus will feature the iconic coastline views of Highway 1, which has reopened after a massive effort by Caltrans to repair damage from a 2017 landslide, as the race runs 133.3 miles from WeatherTech Raceway Laguna Seca to Morro Bay.
The Amgen Tour of California Women's Race empowered with SRAM UCI WorldTour race showcasing the world’s best women cyclists will run concurrently for the final three days of the men’s event, beginning in Ventura May 16-18.
Amgen Tour of California fans can connect with the race through all of their favorite social media platforms and use #AmgenTOC to join the conversation.
Amgen, title sponsor of the Amgen Tour of California for the 14th consecutive year, is a biotechnology company in the race to dramatically improve patients’ lives and the company leverages its sponsorship to raise awareness and connect with patients through its Breakaway initiatives.
On May 1, Amgen launched the Breakaway Challenge, a national social fitness movement to motivate individuals to take action in their health and to support the fight against heart disease and cancer. Amgen’s Breakaway Challenge joins together Breakaway from Cancer® and Breakaway from Heart Disease™ and urges participants to turn their walking, running or cycling miles into support for eight nonprofit advocacy organizations that are dedicated to cancer and heart disease research.
Amgen has teamed up with Strava, a social fitness app that tracks cycling and running activities, to create the Breakaway Challenge. Strava will aggregate the total miles contributed to the Breakaway Challenge with the goal to collectively reach as many miles as possible with Amgen matching the first 400,000 miles with a $400,000 donation evenly distributed to the independent, nonprofit partners. Today, 11,763,929 miles toward the Breakaway Challenge have been logged. Join Amgen and make this the biggest Challenge ever. Learn more at www.AmgenBreakawayChallenge.com .
“Building and connecting with communities is at the core of Amgen’s Breakaway initiatives and we are incredibly pleased with the community forming as part of the Breakaway Challenge,” said Corrine Le Goff, Senior Vice President, General Manager, General Medicine, Amgen. “Amgen is more committed than ever to scientific innovation and to building a community of support for patients. It takes a team to win the Amgen Tour of California, it takes a team to make great strides in scientific innovation and it takes a community to educate, support and empower patients. Join our Breakaway Challenge community today.”
Created by Amgen in 2005, Breakaway from Cancer® is a national initiative to raise awareness of the important resources available to people impacted by cancer – from prevention to survivorship. And, the Breakaway from Heart Disease™ initiative encourages Americans to take charge of their risk of heart disease through diagnostic screenings as well as information and tools related to physical activity and healthy eating. Learn more at www.breakawayfromcancer.com and www.breakawayfromheartdisease.com.
Throughout the race, Amgen will honor and celebrate patients. Each day the race will be started by a cancer or heart disease survivor, and the Most Courageous jersey will be awarded by a survivor as well. Cyclists will also wear Breakaway “I Ride For” bibs recognizing someone in their life impacted by cancer or heart disease.
“Creating powerful connections in the communities is part of our mission to develop vital medicines and serve more patients who suffer from serious diseases. This is how we make a difference in the world; every patient, every time,” continued Le Goff. “Today’s healthcare options for treating serious illness are more promising than at any other time in our history. Now more than ever, patients living with serious diseases such as cancer and cardiovascular disease can look to the future with greater hope. Our sponsorship of the Amgen Tour of California gives us a platform to discuss, educate and empower patients to have hope and believe in innovation to live a longer, healthier life.”
For more information, visit www.amgen.com.
About the Amgen Tour of California
The Amgen Tour of California and the Amgen Tour of California Women's Race empowered with SRAM are Tour de France-style cycling road races created and presented by AEG. Running concurrently, the races challenge the world's top professional cycling teams to compete along demanding courses that traverse hundreds of miles of California's iconic highways, byways and coastlines each spring. The teams chosen to participate have included Olympic medalists, Tour de France contenders and World Champions, and award important, world-ranking points to the top finishers. For more information visit the Amgen Tour of California on Instagram, Facebook, Twitter, YouTube or www.amgentourofcalifornia.com.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be the world's largest independent biotechnology company, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Headquartered in Los Angeles, California, AEG is the world’s leading sports and live entertainment company. With offices on five continents, AEG operates in the following business segments: AEG Facilities, which is affiliated with or owns, manages or consults with more than 150 preeminent arenas, stadiums, theaters, clubs and convention centers around the world including STAPLES Center, The O2 Arena, the Sprint Center and the Mercedes-Benz Arenas; AEG Presents, which is dedicated to all aspects of live contemporary music performances, including producing and promoting global and regional concert tours, music and special events and world-renowned festivals; AEG Real Estate, which develops world-class venues, as well as major sports and entertainment districts like STAPLES Center and L.A. LIVE; AEG Sports, which is the world’s largest operator of sports franchises and high-profile sporting events; and AEG Global Partnerships, which oversees worldwide sales and servicing of sponsorships including naming rights, premium seating and other strategic partnerships. Through its worldwide network of venues, portfolio of powerful sports and music brands, AXS.com ticketing platform, AXS cable television channel and its integrated entertainment districts, AEG entertains more than 100 million guests annually. More information about AEG can be found at www.aegworldwide.com.
# # #
Michael Roth, AEG
Josh Levitt, Canvas Blue